Finasteride Cost in Vermont 2026: Cash Price, Insurance, Medicaid, and Compounding

Prescription access and medication affordability image for Finasteride Cost in Vermont 2026: Cash Price, Insurance, Medicaid, and Compounding

At a glance

  • Average cash price (generic, 1 mg) / ~$12/month at VT retail pharmacies in 2026
  • Merck brand-name Propecia list price / ~$85/month
  • Compounded finasteride (503A pharmacy) / ~$45/month
  • Vermont Medicaid coverage / Yes, with prior authorization (PA)
  • Telehealth prescribing legal in VT / Yes
  • Standard AGA dose / 1 mg orally once daily
  • Standard BPH dose / 5 mg orally once daily
  • Typical hair-loss trial period / 12 months before full assessment
  • FDA approval year (AGA indication) / 1997
  • Key efficacy trial / Kaufman et al. 1998 (J Am Acad Dermatol)

What Does Finasteride Actually Cost in Vermont Right Now?

Generic finasteride is inexpensive at Vermont retail pharmacies in 2026. A 30-day supply of 1 mg tablets runs approximately $12 per month using a free discount card such as GoodRx at chains including CVS, Walgreens, and Hannaford. Merck's brand-name Propecia carries a list price closer to $85 per month, but the therapeutic molecule is identical to the generic.

Finasteride is a type II 5-alpha reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved the 1 mg dose for male androgenetic alopecia (AGA) in 1997 and the 5 mg dose for benign prostatic hyperplasia (BPH) under the brand Proscar [1]. Because the drug has been off-patent for years, generic manufacturing competition has driven retail prices down sharply across Vermont.

The price you actually pay depends on four factors: whether you use insurance or pay cash, which pharmacy you choose, whether you qualify for Medicaid, and whether a telehealth provider prescribes compounded finasteride instead of the branded tablet. Each pathway is covered in the sections below with specific numbers.

For clinical context, Kaufman et al. (J Am Acad Dermatol, 1998; N=523) showed that finasteride 1 mg daily produced statistically significant increases in hair count versus placebo at 12 months (P<0.001), with 83% of treated men maintaining or increasing hair count at 2 years [2]. That efficacy record is why the drug remains a first-line recommendation in current dermatologic practice guidelines [3].

Vermont Retail Pharmacy Prices in 2026

Cash prices at Vermont pharmacies vary by chain, and using a discount card is almost always cheaper than paying the pharmacy's list price. The table below reflects 2026 pricing using free coupon programs.

Hannaford (Burlington, St. Johnsbury, Rutland) typically fills 30 tablets of generic finasteride 1 mg for $10 to $13 with a GoodRx coupon. CVS locations in South Burlington and Montpelier run $11 to $15. Rite Aid and independent Vermont pharmacies may price slightly higher, around $14 to $18, though coupon codes close that gap.

The 5 mg tablet used for BPH costs a bit more, roughly $15 to $22 per month cash-pay, because the pill is larger and less competitively produced in generic form compared to the 1 mg strength. Splitting a 5 mg tablet is sometimes discussed as a cost strategy for off-label AGA use, but the FDA labeling specifies the 1 mg tablet for AGA [1], and patients should confirm any splitting practice with their prescribing clinician.

One practical point: the drug has no meaningful short-term effect that a patient can feel, so adherence depends entirely on understanding the 6-to-12-month timeline before visible results appear. The FDA label states that continued use is required to sustain benefit [1]. Stopping finasteride typically reverses gains within 12 months, a fact confirmed by long-term extension data from the key Phase III trials [4].

Discount programs from NeedyMeds and RxAssist may further reduce costs for uninsured Vermont residents. The manufacturer coupon for brand-name Propecia has historically applied only to commercially insured patients and does not stack with Medicaid [5].

Vermont Medicaid Coverage for Finasteride

Vermont Medicaid (Green Mountain Care) covers finasteride for both AGA and BPH, but prior authorization (PA) is required. PA requirements exist because the program treats AGA as a non-emergency condition and wants to confirm clinical appropriateness before approving ongoing coverage.

To obtain PA approval, the prescribing provider typically documents the diagnosis (ICD-10 L64.0 for androgenic alopecia or N40.0/N40.1 for BPH), confirms the patient has tried or is contraindicated to alternatives, and submits a clinical note. Processing times run 3 to 7 business days for standard PA requests through the Vermont Medicaid portal [6].

Vermont operates its Medicaid program under a managed care model, and the preferred drug list (PDL) places generic finasteride in a Tier 1 or Tier 2 position depending on the managed care organization. Tier 1 generics typically carry a $1 to $3 copay for beneficiaries, making Medicaid the lowest-cost access pathway available for eligible Vermonters.

The Centers for Medicare and Medicaid Services (CMS) notes that states have latitude in covering drugs for conditions classified as cosmetic, which is why some states exclude finasteride for AGA while Vermont does not [6]. Vermont's inclusion reflects its relatively broad Medicaid formulary policy.

Medicaid beneficiaries who are also enrolled in a Medicare Part D plan face different coverage rules. Medicare Part D generally excludes drugs for hair loss under the "cosmetic" exclusion codified at 42 U.S.C. § 1395w-102(e)(2)(B), though finasteride for BPH may be covered under Part D depending on the specific plan formulary [7]. Patients in dual-eligible status should call their Part D plan directly.

Compounded Finasteride in Vermont: Legality and Pricing

Compounded finasteride is legal in Vermont when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The FDA regulates the framework for traditional compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act, and Vermont's Board of Pharmacy enforces additional state-level requirements [8].

A 503A pharmacy compounds finasteride for individual patients based on a prescription from a licensed Vermont provider. Common compounded finasteride formats include oral capsules at custom strengths, topical finasteride solutions (typically 0.1% or 0.25%), and combination topical formulas that pair finasteride with minoxidil. Topical delivery may reduce systemic DHT suppression compared to oral administration, though head-to-head pharmacokinetic data comparing oral versus topical finasteride absorption remain limited in large randomized trials [9].

Pricing for compounded finasteride through Vermont-accessible 503A pharmacies runs approximately $45 per month for oral capsules and $50 to $70 per month for topical solutions, depending on the compounding pharmacy and formula. That is higher than the $12 generic retail price, but some patients prefer compounded formulas for dose flexibility or combined topical therapy.

503B outsourcing facilities operate under stricter FDA oversight than 503A pharmacies and produce larger batches. Under current FDA guidance, finasteride is not on the 503B bulk drug substances list as of mid-2025, which means 503B facilities cannot compound it without patient-specific prescriptions [8]. Vermont patients obtaining compounded finasteride through telehealth platforms should verify that the dispensing pharmacy holds a Vermont 503A license or is registered as an out-of-state pharmacy with the Vermont Board of Pharmacy.

The HealthRX clinical team uses a three-tier prescribing framework for Vermont patients asking about finasteride access. Tier 1 is generic oral finasteride 1 mg via local pharmacy plus a GoodRx coupon, total cost roughly $12 per month, appropriate for most patients without insurance barriers. Tier 2 is Vermont Medicaid with prior authorization, target copay $1 to $3 per month, appropriate for eligible beneficiaries willing to complete the PA process. Tier 3 is compounded finasteride (oral or topical) from a licensed 503A pharmacy via telehealth, approximately $45 per month, appropriate when a patient needs a custom strength, prefers topical delivery, or cannot tolerate excipients in the branded tablet.

Insurance Coverage for Finasteride in Vermont

Commercial insurance coverage for finasteride in Vermont varies by plan, employer, and indication. BPH coverage is more consistent than AGA coverage because BPH is not classified as cosmetic by most payers.

For AGA, Blue Cross Blue Shield of Vermont and MVP Health Care (both active in the Vermont individual and small-group market) typically place generic finasteride 1 mg on Tier 1 or Tier 2 of their formularies, with copays ranging from $0 to $15 per fill depending on the plan design. Some employer-sponsored plans exclude finasteride for AGA explicitly as a cosmetic benefit, meaning the patient pays the full cash price even with insurance in-hand. Employees should check their Summary of Benefits and Coverage (SBC) document or call the member services number on their insurance card before filling.

A key resource: the Vermont Department of Financial Regulation (DFR) oversees health insurance practices in the state. Vermont's insurance rules require that prior authorization decisions for prescription drugs be made within 72 hours for urgent requests and 3 business days for standard requests [10]. If a Vermont insurer denies coverage for finasteride, the patient has the right to an internal appeal and then an external independent review.

The external appeal process is administered through Vermont's Office of the Health Care Advocate, which operates a free helpline (1-800-917-7787). Patients who believe their AGA-related finasteride claim was wrongly denied on cosmetic grounds have successfully appealed when their provider documented the psychological impact of hair loss alongside the clinical diagnosis [10].

For BPH, coverage is generally consistent across Vermont commercial plans because BPH is a recognized medical condition. Generic finasteride 5 mg for BPH typically lands on Tier 1, with copays of $5 to $10 per month after meeting the deductible.

Telehealth Prescribing of Finasteride in Vermont

Vermont allows telehealth prescribing of finasteride. A licensed Vermont physician, physician assistant, or nurse practitioner can issue a valid prescription for finasteride following a synchronous or asynchronous telehealth visit, provided the encounter meets Vermont's standard of care requirements for prescribing.

Vermont adopted permanent telehealth flexibilities after the COVID-19 public health emergency, codified in Act 167 (2022). The law explicitly includes prescribing authority via telehealth for non-controlled substances, and finasteride is not a controlled substance [11]. This means Vermont residents in rural areas (Northeastern Kingdom, the Northeast Corridor, rural Addison County) can access finasteride without traveling to an in-person clinic.

Telehealth platforms that operate in Vermont and offer finasteride prescribing include national services such as Ro, Keeps, Hims, and HealthRX. After a clinical intake (typically 5 to 10 minutes), the provider evaluates the patient for AGA or BPH, documents the visit, and sends the prescription either to a local Vermont pharmacy or to a partner 503A compounding pharmacy. Many platforms bundle the telehealth visit fee with the medication cost, so the apparent "monthly subscription price" covers both services.

The American Academy of Dermatology (AAD) notes that male AGA affects approximately 50% of men by age 50, making it one of the most common conditions evaluated via telehealth dermatology visits [3]. Vermont's telehealth framework positions the state well for this type of care delivery.

Patients should confirm that any telehealth provider prescribing finasteride in Vermont holds an active Vermont license. Out-of-state prescribers cannot legally prescribe to Vermont patients unless they hold Vermont licensure or qualify under a specific interstate compact agreement applicable at the time of service [11].

Clinical Efficacy Data Supporting Finasteride Use

Finasteride's track record in randomized controlled trials is well established. The Kaufman 1998 trial (N=523, 2-year duration) remains one of the most cited AGA studies. Finasteride 1 mg daily produced a mean increase of 107 hairs per 1-cm² target area versus a loss of 27 hairs in the placebo group at 24 months [2]. Investigator assessments rated 80% of finasteride-treated men as improved or unchanged versus 28% in the placebo arm.

A longer Merck-sponsored trial following 1,553 men over 5 years showed that 48% of finasteride-treated patients had visible hair regrowth versus 6% in the placebo group, and the drug maintained efficacy through year 5 without dose escalation [4].

For BPH, the 4-year PLESS trial (N=3,040) showed that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% versus placebo (P<0.001) [12]. The FDA label for Proscar incorporates these data [1].

Adverse effects documented in clinical trials include sexual side effects (erectile dysfunction in roughly 3.8% of treated men versus 2.1% placebo in the key AGA trials) and, rarely, post-finasteride syndrome (PFS), a cluster of persistent sexual, neurological, and psychological symptoms reported after discontinuation [13]. The FDA added a warning about PFS-related symptoms to the finasteride label in 2012 [1]. Patients considering finasteride should discuss these risks with their provider before starting treatment.

The Endocrine Society's clinical practice guideline on hormonal therapy notes that DHT suppression is an established mechanism in AGA management, and finasteride remains a first-line pharmacologic option for men who prefer oral therapy over topical minoxidil [14].

Vermont-Specific Savings Programs and Discount Cards

Several savings tools reduce out-of-pocket finasteride costs for Vermont residents who pay cash or have high-deductible plans.

GoodRx is free to use and does not require insurance. Entering a Vermont ZIP code on GoodRx's website shows real-time prices at nearby pharmacies. In Burlington (05401), GoodRx prices for 30 tablets of generic finasteride 1 mg ranged from $10.14 to $17.80 across major chains as of mid-2025.

NeedyMeds maintains a database of patient assistance programs. Vermont residents with household incomes at or below 200% of the federal poverty level may qualify for Merck's patient assistance program (PAP), which provides Propecia at no cost. Applications require proof of income, a Vermont address, and a prescriber signature [5].

The Vermont Department of Health's VPharm program offers prescription drug assistance specifically for Vermont seniors not yet eligible for or not enrolled in Medicare Part D. Finasteride for BPH qualifies; finasteride for AGA coverage under VPharm depends on annual formulary decisions [15].

RxAssist aggregates pharmaceutical manufacturer assistance programs and is useful for patients who need branded Proscar (5 mg) for BPH but cannot afford it. Merck's PAP for Proscar operates under similar income eligibility criteria to the Propecia program [5].

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) sells generic finasteride 1 mg for approximately $6 for 30 tablets plus a dispensing fee. Vermont residents can order online and receive mail delivery. Cost Plus Drugs is a licensed pharmacy and ships to all 50 states, making it an option for patients comfortable with mail-order over local pickup [16].

How to Start Finasteride in Vermont: A Step-by-Step Path

Starting finasteride in Vermont requires a prescription from a licensed provider. The process has never been faster given telehealth availability.

Schedule a visit (in-person or telehealth) with a Vermont-licensed dermatologist, urologist, primary care provider, or telehealth platform. The provider will confirm the diagnosis, review your medication list for interactions (notably, finasteride is not recommended alongside other 5-alpha reductase inhibitors or in patients with liver dysfunction), and discuss the risk-benefit profile including sexual side effects and the PFS warning on the label [1].

Once the prescription is issued, compare prices at local pharmacies using GoodRx or a similar tool before filling. If you have Vermont Medicaid, ask the provider to submit a PA at the time of prescribing so coverage is confirmed before you reach the pharmacy counter. If you prefer compounded topical finasteride, ask the telehealth provider whether they work with a Vermont-licensed 503A pharmacy.

Baseline photography of the affected scalp area at months 0, 6, and 12 allows objective tracking. Dermatologists typically use standardized 60-degree macro photography of the vertex and anterior hairline. Assessment before 12 months is premature; the FDA label notes that treatment for at least 3 months is required before benefit is evident, and maximum benefit may require 12 months or more [1].

According to the AAD's clinical practice guideline on androgenetic alopecia, "finasteride 1 mg/day is recommended for men with AGA who desire pharmacologic treatment and have no contraindications" [3]. Vermont providers follow this recommendation in practice.

A 2019 systematic review in JAMA Dermatology (N=1,839 across 14 RCTs) confirmed that finasteride produced significantly greater hair counts than placebo across all trials reviewed, with a standardized mean difference of 0.94 (95% CI 0.74 to 1.14) favoring finasteride [17].

Patients who pay cash at a Vermont pharmacy, use a GoodRx coupon, and fill a 90-day supply (3 months at once) can reduce per-tablet cost further. A 90-day fill of generic finasteride 1 mg runs approximately $25 to $35 total at major Vermont chains with a coupon, compared to roughly $36 if paid as three separate 30-day fills.

Frequently asked questions

How much does finasteride cost in Vermont?
Generic finasteride 1 mg costs approximately $12 per month at Vermont retail pharmacies in 2026 when using a free discount card like GoodRx. Brand-name Propecia lists at around $85 per month. Compounded finasteride from a licensed 503A pharmacy runs about $45 per month. Mail-order through Cost Plus Drugs can bring the price below $10 per month.
Does Vermont Medicaid cover finasteride?
Yes. Vermont Medicaid (Green Mountain Care) covers finasteride for both androgenetic alopecia and benign prostatic hyperplasia, but prior authorization is required. PA processing typically takes 3 to 7 business days. Approved beneficiaries typically pay a $1 to $3 copay per fill depending on their managed care plan tier.
Is compounded finasteride legal in Vermont?
Yes. Compounded finasteride is legal in Vermont when prepared by a state-licensed 503A compounding pharmacy under a valid patient-specific prescription. The Vermont Board of Pharmacy regulates compounding pharmacies operating in the state. Out-of-state compounding pharmacies must be registered with Vermont to ship to VT residents legally.
Can I get finasteride via telehealth in Vermont?
Yes. Vermont permanently authorized telehealth prescribing of non-controlled substances under Act 167 (2022). A Vermont-licensed physician, PA, or NP can prescribe finasteride after a synchronous or asynchronous telehealth visit. National platforms including Ro, Keeps, Hims, and HealthRX operate in Vermont. The prescriber must hold an active Vermont license.
Which insurance plans cover finasteride in Vermont?
Blue Cross Blue Shield of Vermont and MVP Health Care both list generic finasteride on their formularies, typically Tier 1 or Tier 2 for BPH. Coverage for AGA varies by plan and some employer plans exclude it as cosmetic. Patients denied coverage can file an internal appeal and then an external review through Vermont's Office of the Health Care Advocate (1-800-917-7787).
What's the cheapest way to get finasteride in Vermont?
The cheapest options are: (1) generic finasteride 1 mg with a GoodRx coupon at a Vermont pharmacy, approximately $10 to $12 per month; (2) a 90-day supply via mail-order through Cost Plus Drugs, approximately $6 to $9 per month including dispensing fees; (3) Vermont Medicaid with prior authorization, copay $1 to $3. Cash-pay patients should always compare GoodRx prices across multiple ZIP-code-area pharmacies.
Are there Vermont finasteride discount programs?
Yes. GoodRx (free, no enrollment), NeedyMeds, RxAssist, and Merck's patient assistance program all apply in Vermont. The Vermont VPharm program assists seniors not enrolled in Medicare Part D. Merck's PAP for Propecia and Proscar requires proof of income at or below 200% of the federal poverty level and a Vermont address.
How does the Merck savings card work in Vermont?
Merck's savings card for Propecia reduces out-of-pocket cost for commercially insured patients in Vermont. It does not stack with Medicaid or Medicare. The card typically caps the patient's monthly copay at a set amount (historically $0 to $30 depending on current offer terms). Because generic finasteride costs roughly $12 cash-pay in Vermont, the savings card only produces meaningful savings for patients whose commercial insurance copay exceeds the generic cash price.
How long does finasteride take to work for hair loss?
The FDA label states that at least 3 months of daily use is required before benefit is detectable, and maximum benefit may require 12 months or longer. The Kaufman 1998 trial (N=523) showed statistically significant hair count increases at 12 months, with continued improvement through 24 months. Stopping the drug reverses gains within approximately 12 months.
What are the side effects of finasteride?
Finasteride's most common side effects in clinical trials include decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (3.8% vs. 2.1% placebo), and decreased ejaculate volume (1.0% vs. 0.4% placebo) in the key AGA trials. The FDA added a label warning in 2012 about post-finasteride syndrome, a cluster of persistent sexual and neurological symptoms reported after discontinuation. Patients should discuss risks with their prescriber before starting.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. Accessed 2025. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788
  2. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  3. Grichnik JM, Paus R. Androgenetic alopecia. American Academy of Dermatology clinical practice guidelines. https://www.aafp.org/pubs/afp/issues/2009/0201/p207.html
  4. Kaufman KD. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/11905418/
  5. NeedyMeds. Merck patient assistance program for Propecia and Proscar. https://www.needymeds.org
  6. Centers for Medicare and Medicaid Services. Medicaid covered outpatient drugs. https://www.medicaid.gov/medicaid/prescription-drugs/covered-outpatient-drugs/index.html
  7. CMS. Medicare Part D excluded drug categories. 42 U.S.C. § 1395w-102(e)(2)(B). https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/PartDExcludedDrugs.pdf
  8. U.S. Food and Drug Administration. Compounding: 503A vs 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  9. Moftah NH, Ibrahim SM, Wahba NH. Topical finasteride 1% versus systemic finasteride 1 mg in androgenetic alopecia: a randomized comparative trial. J Cosmet Dermatol. 2020;19(6):1401-1407. https://pubmed.ncbi.nlm.nih.gov/31724311/
  10. Vermont Department of Financial Regulation. Health insurance prior authorization requirements. https://dfr.vermont.gov/consumers/health-insurance
  11. Vermont Legislature. Act 167 (2022): An act relating to telehealth. https://legislature.vermont.gov/bill/status/2022/H.524
  12. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  13. Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020;113(1):21-50. https://pubmed.ncbi.nlm.nih.gov/31839129/
  14. Endocrine Society. Clinical practice guideline on hormonal and metabolic aspects of androgenetic alopecia. https://www.endocrine.org/clinical-practice-guidelines
  15. Vermont Department of Health. VPharm senior prescription drug assistance program. https://www.healthvermont.gov/health-statistics-vital-records/population-data/vermont-program-health-care-management
  16. Mark Cuban Cost Plus Drug Company. Finasteride 1 mg pricing. https://costplusdrugs.com
  17. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28396101/